Dr. Corinne Hohl is a scientist at the Centre for Clinical Epidemiology and Evaluation (C2E2) and an associate professor in the Department of Emergency Medicine at the University of British Columbia (UBC). She practices emergency medicine at Vancouver General Hospital, and is a member of the Canadian Drug Safety and Effectiveness Research Network and the Canadian Network for Advanced Interdisciplinary Methods for Comparative Effectiveness Research. In 2020, she became the Chair of the Canadian COVID-19 Emergency Department Rapid Response Network.
Dr. Hohl’s main research interests are in emergency medicine, drug safety and effectiveness, adverse drug event surveillance, COVID-19 and pandemic preparedness. Together with her team, she has developed interventions to improve the recognition and treatment of patients affected by adverse drug events in emergency departments. She is presently working on a randomized controlled trial to understand whether automated communication of adverse drug event information using a software called ActionADE prevents re-exposures to medications that previously caused harm. Implementation of ActionADE will provide better data for research in drug safety and effectiveness, and post-marketing surveillance of prescribed medications. For her work on adverse drug events, she was awarded a Best Paper Award from the American College of Emergency Physicians in 2011, and a New Investigator Award from the Canadian Institutes of Health Research in 2012. Dr. Hohl was awarded the Teacher of the Year Award in 2013 by the UBC Fellows of The Royal College of Physicians of Canada Emergency Medicine Residency Program. UBC awarded Dr. Hohl with an Excellence in Early Career Mentorship award in 2019.
News and Awards
- Trials -
- CMAJ open -
- Academic emergency medicine : official journal of the Society for Academic Emergency Medicine -
- Annals of emergency medicine -
- CMAJ open -